Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::

林妏霙 (Wen-Ying Lin)

[簡介]

  • 學歷
    • 國立陽明交通大學 醫學系 (2019)
    • 美國密蘇里大學 醫學藥理學 博士 (2016)
  • 經歷
    現職:
    • 2026- 迄今 臺北榮民總醫院 腫瘤醫學部腫瘤內科 主治醫師
    • 2026- 迄今 國立陽明交通大學醫學院 藥理學研究所 助理教授
    經歷:
    • 2023- 2026 臺北榮民總醫院 腫瘤醫學部腫瘤內科 總醫師
    • 2020- 2023 臺北榮民總醫院 內科部 住院醫師
    • 2019- 2020 臺北榮民總醫院 不分科住院醫師
    • 2018- 2018 美國杜克大學醫學中心 臨床實習
  • 醫療專長
    1. 乳癌、中樞神經系統癌、肺癌、癌症安寧
  • 證照
    內科專科醫師、腫瘤內科專科醫師
  • 語言專長
    英文、中文、台語

[著作]

  • Lin WY, Tsai CK, Yeh CM, Liu CJ. Identifying risk factors for methotrexate-induced acute kidney injury despite full prevention in patients with primary central nervous system lymphoma. Toxicol Appl Pharmacol. 2025 Jun 6;502:117436. doi: 10.1016/j.taap.2025.117436.
  • Ho YC, Chang MC, Lin WY, Wu CY, Liu SY, Chuang C, Juan CH, Liu CJ, Lin YT. Prognostic factors of disease progression in patients with mild-to-moderate COVID-19 on early remdesivir treatment in Taiwan. J Infect Public Health. 2025 Feb 14;18(5):102705. doi: 10.1016/j.jiph.2025.102705.
  • Chang MC, Wu PF, Ho YC, Lin WY, Wu CY, Liu SY, Liu CJ, Lin YT. Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment. J Infect Public Health. 2024 Jul;17(7):102460. doi: 10.1016/j.jiph.2024.05.048.
  • Lin WY, Tsai CK, Yeh CM, Chian T, Liu YC, Wang HY, Liu CJ. Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patients. Cancer Med. 2023;12(3):3013-3026. doi: 10.1002/cam4.5215.
  • Wu WT*, Lin WY*, Chen YW, Lin CF, Wang HH, Wu SH, Lee YY. New Era of Immunotherapy in Pediatric Brain Tumors: Chimeric Antigen Receptor T-Cell Therapy. Int J Mol Sci. 2021;22(5):2404. doi: 10.3390/ijms22052404. (*Co-first author)
  • Lin WY, Wang HH, Chen YW, Lin CF, Fan HC, Lee YY. Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies. Int J Mol Sci. 2020;21(22):8655. doi: 10.3390/ijms21228655.
  • Lin WY, Chen YW, Lin CF, Yang YP, Wang ML, Hung KF, Chiou SH. Emerging trends in gene-modified-based chimeric antigen receptor-engineered T-cellular therapy for malignant tumors: The lesson from leukemia to pediatric brain tumors. J Chin Med Assoc. 2020;83(8):719-724. doi: 10.1097/jcma.0000000000000358.